The Trump administration's efforts to address the causes of chronic diseases will all be based on "unbiased science," HHS ...

Lawmakers in Michigan have introduced a package of bills designed to lower costs and expand healthcare access. Senate Bill 3 ...

All you need to do is swipe down from the top-right of your iPhone and press and hold down on the new power button in the top ...

If big pharma was hoping that there would not be drug price negotiations under President Trump, they seem to have had their hopes dashed. That ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

You know them as Flo, the Progressive Insurance saleswoman; Mayhem, the human embodiment of disasters covered by Allstate; and the unstoppable dancer from the Jardiance diabetes drug ads.

A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...

The Food and Drug Administration this week approved a new type of painkiller that doesn’t carry the risk of addiction or overdose associated with opioid medications. The drug, suzetrigine ...

The draft also outlined strategies device companies can take to increase transparency and mitigate bias in their models. In ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

(Reuters) - The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under President Donald Trump's administration following criticism from ...